asciminib,bosutinib
novartis,pfizer
['leukemia', 'cml', 'myeloid', 'novartis', 'novartisnews']
novartis presents longer-term analysis from ascembl trial for patients with chronic myeloid leukemia (#cml) in chronic phase at #asco22. #novartisnews
The official account for @Novartis News & Media Updates. For media inquiries: media.relations@novartis.com. See our community guidelines: https://t.co/b4Kyh4UvNm